Laurence F. O.
- Country
- France
- Department
- #2202:Genetics department
Research Overview
- Evaluation of Long-Term Safety and Efficacy of Alpelisib in Patients with PIK3CA-Related Overgrowth Spectrum (PROS) Following Participation in Study CBYL719F12002
- Efficacy and Safety of Alpelisib in Pediatric and Adult Patients with PIK3CA-Related Overgrowth Spectrum: A Phase II Randomized, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 3 of 17 partner sites.
Specializations
Genetic Disorders
The investigator specializes in studying PIK3CA-Related Overgrowth Spectrum (PROS), a rare genetic condition characterized by tissue overgrowth and vascular anomalies.
- Genetic mutations research
- Tissue overgrowth disorders
- Rare disease management
Their work encompasses the clinical evaluation and therapeutic management of patients affected by genetic overgrowth conditions.
Therapeutic Development
The investigator focuses on evaluating novel therapeutic approaches for treating genetic overgrowth disorders, with particular attention to long-term safety and clinical outcomes.
- Treatment safety assessment
- Long-term therapeutic monitoring
- Clinical response evaluation
Their research aims to establish effective treatment protocols for patients with genetic overgrowth conditions.
Clinical Management
The investigator's expertise extends to the comprehensive clinical management of rare genetic disorders, focusing on patient monitoring and treatment optimization.
- Patient safety monitoring
- Treatment tolerability assessment
- Long-term care protocols
Their work involves developing strategies for prolonged therapeutic intervention in genetic disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.